Status of ParaGard IUD Litigation
January 2023 ParaGard IUD Litigation Update
On September 28, 2022, Judge May ordered the initial scheduling of important dates in the Paragard IUD litigation.
September 2022 ParaGard IUD Litigation Update
A total of 45,382 adverse events associated with the ParaGard IUD have been reported — 1,719 of which were reported in 2022
February 2022 ParaGard Litigation Update
The multidistrict litigation continues to grow, with more cases being added daily. The FDA shows that more than 43,000 adverse events have been reported from women using the ParaGard IUD, known as T380A.
Primary Issues in the ParaGard Litigations
The core issue of the case is that the IUD has been shown to break upon removal, causing immense injury and complications from surgically repairing the injuries. The plaintiffs also allege that Teva and CooperSurgical failed to properly warn them or their doctors of the risks.
Manufacturing and Design Defects
The ParaGard IUD T380 A has a unique design. It is T-shaped, which means its arms stick out straight from the center cylinder.
The plaintiffs allege that this design causes the IUD to break off, most notably during removal, even when removal takes place by a train physician or physician’s staff.
The broken pieces can then migrate to the uterus, causing organ damage and sometimes requiring surgery. In some horrific cases, women may require a hysterectomy, which leaves them unable to have children in the future.
Failure to Warn
Who are the Defendants in the ParaGard IUD Litigation?
The primary plaintiffs are Teva Pharmaceuticals and CooperSurgical Inc., who manufactured ParaGard.
Teva Pharmaceutical Industries Ltd.
Has ParaGard been recalled?
No, the FDA has not recalled ParaGard. However, it sent a warning letter to CooperSurgical on Feb. 12, 2021.
What is the ParaGard IUD
ParaGard IUD is a birth control device that was designed to be effective for up to 12 years.
The ParaGard IUD can result in several complications, according to the FDA.